On December 23, 1971, President Richard Nixon signed the National Cancer Act.
Last Tuesday, December 13, the U.S. Senate passed Senate Resolution 347, commemorating the 40th anniversary of that historic signing and noting that we have made great progress, but there remains more to do in our search for a cure for cancer.
On Sunday, December 19, author Betsy de Parry posted an editorial on AnnArbor.com about how Senate Resolution 347 reaffirms that cancer research is a national priority. She asks legislators and the public to “renew meaningful conversation that will lead to reinvigorating the robust commitment to cancer research that was launched 40 years ago” because, as she states, so many lives depend on it.
At the U-M Health System, our commitment to cancer research and clinical care has never been stronger. In fact, Cancer is one of our strategic priorities.
As we strive to create the future of health care through discovery at Michigan, we are committed to further integrating our innovative research and multidisciplinary, patient-focused clinical care to prevent, diagnose and treat cancer.
One of our strengths is being home to national expertise in cancer, like that which de Parry highlights in her piece when she refers to her Dr. Max Wicha-inspired historical perspective on the past 40 years and Dr. Gary Hammer’s involvement in crafting the language of Senate Resolution 347 to highlight the importance of studying uncommon cancers as a way to help us understand the genomic behaviors of all cancers.
What do you think of our progress in the fight against cancer? Are we doing enough? Are we making good progress? Share your perspective on Medicine That Speaks!